Hepatic fascioliasis

Case report and review

Salha Abdul-Hadi, Rosa Contreras, Claudio Tombazzi, Marta Alvarez, Maribel Melendez

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and a few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis

Original languageEnglish (US)
Pages (from-to)69-73
Number of pages5
JournalRevista do Instituto de Medicina Tropical de Sao Paulo
Volume38
Issue number1
DOIs
StatePublished - Jan 1 1996

Fingerprint

triclabendazole
Fascioliasis
Liver
Eosinophilia
Abdominal Pain
Fever
Recurrence

All Science Journal Classification (ASJC) codes

  • Infectious Diseases

Cite this

Hepatic fascioliasis : Case report and review. / Abdul-Hadi, Salha; Contreras, Rosa; Tombazzi, Claudio; Alvarez, Marta; Melendez, Maribel.

In: Revista do Instituto de Medicina Tropical de Sao Paulo, Vol. 38, No. 1, 01.01.1996, p. 69-73.

Research output: Contribution to journalArticle

Abdul-Hadi, Salha ; Contreras, Rosa ; Tombazzi, Claudio ; Alvarez, Marta ; Melendez, Maribel. / Hepatic fascioliasis : Case report and review. In: Revista do Instituto de Medicina Tropical de Sao Paulo. 1996 ; Vol. 38, No. 1. pp. 69-73.
@article{232b7eadfda44969be218ddcab0336cc,
title = "Hepatic fascioliasis: Case report and review",
abstract = "A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and a few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis",
author = "Salha Abdul-Hadi and Rosa Contreras and Claudio Tombazzi and Marta Alvarez and Maribel Melendez",
year = "1996",
month = "1",
day = "1",
doi = "10.1590/S0036-46651996000100013",
language = "English (US)",
volume = "38",
pages = "69--73",
journal = "Revista do Instituto de Medicina Tropical de Sao Paulo",
issn = "0036-4665",
publisher = "Instituto de Medicina Tropical de Sao Paulo",
number = "1",

}

TY - JOUR

T1 - Hepatic fascioliasis

T2 - Case report and review

AU - Abdul-Hadi, Salha

AU - Contreras, Rosa

AU - Tombazzi, Claudio

AU - Alvarez, Marta

AU - Melendez, Maribel

PY - 1996/1/1

Y1 - 1996/1/1

N2 - A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and a few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis

AB - A well documented case of hepatic fascioliasis (HF), successfully treated with triclabendazole, is reported. Predominant clinical manifestations were fever, marked eosinophilia and abdominal pain. Triclabendazole was given as two single oral doses of 10 mg/kg each. Neither side effects nor clinical or parasitological relapses were seen after three months of follow up. Based on this experience and a few other similar reports in the literature, triclabendazole might be a valid therapeutical alternative in the treatment of human fascioliasis

UR - http://www.scopus.com/inward/record.url?scp=0029880064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029880064&partnerID=8YFLogxK

U2 - 10.1590/S0036-46651996000100013

DO - 10.1590/S0036-46651996000100013

M3 - Article

VL - 38

SP - 69

EP - 73

JO - Revista do Instituto de Medicina Tropical de Sao Paulo

JF - Revista do Instituto de Medicina Tropical de Sao Paulo

SN - 0036-4665

IS - 1

ER -